News

Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies

Investment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular riskBOSTON--(BUSINESS WIRE)--Elucid, a leading medical…

2 years ago

LENSAR Reports Third Quarter 2023 Results and Provides Business Update

Increased ALLY® Adaptive Cataract Treatment System installed base to 39 systems with a backlog of 8 additional systems for installation…

2 years ago

NervGen Pharma Reports Q3 2023 Financial Results and Operational Updates

Phase 1a/2b clinical trial of NVG-291 underway with dosing of individuals with spinal cord injury; results from chronic cohort expected…

2 years ago

Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer

Vancouver, British Columbia--(Newsfile Corp. - November 9, 2023) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"),…

2 years ago

Nasdaq-Listed AGAPE Forges Ahead with Sustainable Energy Business

KUALA LUMPUR, MALAYSIA / ACCESSWIRE / November 9, 2023 / Homegrown Nasdaq listed AGAPE ATP Corporation ("ATPC" or the "Company")(NASDAQ:ATPC)…

2 years ago

Radical Imaging Announces Integration of FlexView Inside Agora Care

Integration will enable Agora Care to focus on its strengths in solving today's challenges in long-term storage and access to…

2 years ago

Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5M in Grants; Welcomes Kristine Rhodes to Board of Directors

EAGAN, MN / ACCESSWIRE / November 9, 2023 / The Blue Cross and Blue Shield of Minnesota Foundation has awarded…

2 years ago

Medicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp Survival Data in Recurrent Glioblastoma at the Society for Neuro-Oncology 2023 Annual Meeting

TORONTO and HOUSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTC: MDNAF),…

2 years ago

World’s First Observational Trial to Assess Real-World Efficacy of MDMA Treatment

PharmAla, University of Calgary, and Heroic Hearts Canada to partner on a groundbreaking observational trialVANCOUVER, British Columbia, Nov. 09, 2023…

2 years ago